David Altshuler, a prominent geneticist who has played a pivotal role in shaping Vertex Pharmaceuticals’ research strategy for the past…
Browsing: Vertex
Eli Lilly Makes Billion-Dollar Bet on Non-Opioid Pain Drugs Eli Lilly is making a bold move by investing up to…
In recent years, the issue of pain relief has become increasingly complicated and sensitive. While there has been a slight…
The Food and Drug Administration closed out 2024 with a series of significant drug approvals, including new medicines developed by…
